FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

970911000001100: Mesalazine 250mg suppositories 20 suppository (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22587701000001117 Mesalazine 250mg suppositories 20 suppository (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22587801000001114 Mesalazine 250mg suppositories 20 suppository en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mesalazine 250mg suppositories 20 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository Is pack of Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository false Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository Has active ingredient Mesalazine false Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository Has VMP Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository true Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories 20 suppository VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd) 20 suppository Is a True Mesalazine 250mg suppositories 20 suppository Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) 20 suppository Is a False Mesalazine 250mg suppositories 20 suppository Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories (Colorama Pharmaceuticals Ltd) 20 suppository Is a False Mesalazine 250mg suppositories 20 suppository Inferred relationship Existential restriction modifier
Mesalazine 250mg suppositories (J M McGill Ltd) 20 suppository Is a False Mesalazine 250mg suppositories 20 suppository Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start